Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer
- PMID: 18594824
- DOI: 10.1007/s00345-008-0299-3
Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer
Abstract
Objectives: A proposed benefit of laparoscopic retroperitoneal lymph node dissection (LRPLND) is more favorable morbidity in comparison to open retroperitoneal lymph node dissection (RPLND). The objective of this review is to examine and summarize the literature regarding complications in both primary and post-chemotherapy LRPLND (PC-LRPLND) and, where appropriate, we include the opinions of the senior author regarding management.
Methods: A MEDLINE search was performed using the terms "laparoscopy" or "laparoscopic," "retroperitoneal lymph node dissection" or "RPLND," and "testicular neoplasms." Articles were included on the basis of study design and content. For series updated over time, an effort was made to include only the most recent data to avoid duplicate reporting of patients.
Results: In primary LRPLND, vascular injury is the most common complication, occurring in 2.2-20% of reported cases. Bowel injury is rarely reported but potentially catastrophic. Rates of retrograde ejaculation are less than 5%. Chylous ascites and lymphocele are delayed post-operative complications. Rarely reported complications include nerve injury, retroperitoneal hematoma, and ureteral injury requiring internal stent placement. PC-LRPLND is challenging, with high rates of conversion and complications. Hemorrhage is common. Retrograde ejaculation is several-fold more common in PC-LRPLND than in primary LRPLND. No peri-operative mortality has been reported for either LRPLND or PC-LRPLND.
Conclusions: LRPLND and PC-LRPLND are technically demanding. Hemorrhage and vascular injury are the most commonly reported complications. Prospective studies will help clarify the proposed benefits of LRPLND.
Similar articles
-
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.Eur Urol Oncol. 2020 Jun;3(3):382-389. doi: 10.1016/j.euo.2019.08.002. Epub 2019 Sep 8. Eur Urol Oncol. 2020. PMID: 31506250
-
Laparoscopic retroperitoneal lymph node dissection in the management of testis cancer.Cancer Control. 2007 Jul;14(3):258-64. doi: 10.1177/107327480701400309. Cancer Control. 2007. PMID: 17615532 Review.
-
Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ-cell tumors: current status.Urol Clin North Am. 2007 May;34(2):159-69; abstract viii. doi: 10.1016/j.ucl.2007.02.007. Urol Clin North Am. 2007. PMID: 17484921 Review.
-
Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.World J Urol. 2004 Apr;22(1):33-6. doi: 10.1007/s00345-004-0400-5. Epub 2004 Mar 19. World J Urol. 2004. PMID: 15034741 Review.
-
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.J Endourol. 2016 Oct;30(10):1112-1119. doi: 10.1089/end.2016.0458. J Endourol. 2016. PMID: 27533924
Cited by
-
Lymph Node Dissection in Testicular Cancer: The State of the Art and Future Perspectives.Curr Oncol Rep. 2024 Mar 2. doi: 10.1007/s11912-024-01511-y. Online ahead of print. Curr Oncol Rep. 2024. PMID: 38430323 Review.
-
Robotic-assisted laparoscopy in pediatric surgical oncology: a narrative review.Transl Pediatr. 2023 Dec 26;12(12):2256-2266. doi: 10.21037/tp-23-251. Epub 2023 Dec 18. Transl Pediatr. 2023. PMID: 38197107 Free PMC article. Review.
-
Robotic retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma in adolescents: a case series.J Robot Surg. 2023 Dec;17(6):3045-3048. doi: 10.1007/s11701-023-01735-3. Epub 2023 Nov 16. J Robot Surg. 2023. PMID: 37971637
-
Treatment de-escalation for stage II seminoma.Nat Rev Urol. 2023 Aug;20(8):502-512. doi: 10.1038/s41585-023-00727-0. Epub 2023 Mar 7. Nat Rev Urol. 2023. PMID: 36882564 Review.
-
Prospective Clinical Trial of the Oncologic Outcomes and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma.Front Oncol. 2022 Feb 24;12:791140. doi: 10.3389/fonc.2022.791140. eCollection 2022. Front Oncol. 2022. PMID: 35280720 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
